{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:10:38Z","timestamp":1788793838879,"version":"build-2803163510"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WE 4656\/3-1"],"award-info":[{"award-number":["WE 4656\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["NE 490\/16"],"award-info":[{"award-number":["NE 490\/16"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DFG-funded Collaborative Research Center","award":["TRR241"],"award-info":[{"award-number":["TRR241"]}]},{"DOI":"10.13039\/100004807","name":"DFG","doi-asserted-by":"publisher","award":["90\/1048-1"],"award-info":[{"award-number":["90\/1048-1"]}],"id":[{"id":"10.13039\/100004807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The adaptor protein SLP-76 plays a critical role in T-cell receptor signaling and immune activation, yet its relevance in inflammatory bowel disease (IBD) remains unclear. Although calcineurin inhibitors such as cyclosporine A (CsA) are used in severe ulcerative colitis, voclosporin (VCS), a novel calcineurin inhibitor approved for lupus nephritis, has not been systematically evaluated in IBD. We investigated whether SLP-76 is dysregulated in IBD and can be modulated by calcineurin inhibitors. Expression of SLP-76 was analyzed in intestinal biopsy specimens of patients with ulcerative colitis and Crohn\u2019s disease using quantitative PCR (qPCR) and immunofluorescence. PBMCs from patients with IBD and healthy control participants were stimulated with anti-CD3\/CD28 in the presence or absence of CsA or VCS. Downstream effects were analyzed by qPCR, flow cytometry, cytokine, and metabolic profiling. SLP-76 was significantly upregulated in inflamed intestinal tissue and correlated significantly with histological inflammation. No differences were observed in PBMCs between control participants and patients with IBD. Both calcineurin inhibitors reduced phosphorylation of SLP-76 and impaired downstream signaling in CD4+ and CD8+ T cells. However, only VCS significantly decreased total SLP-76 protein and suppressed expression of the early activation marker CD69 and Ras-MAPL signaling. Metabolomic profiling showed that VCS induced distinct metabolic changes compared with CsA. Our findings highlight SLP-76 as a potential immunoregulatory target in IBD and suggest that VCS exerts broader immunosuppressive effects than CsA, supporting its repurposing as a therapeutic strategy.<\/jats:p>","DOI":"10.1093\/jimmun\/vkag175","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:01:39Z","timestamp":1785006099000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming"],"prefix":"10.1093","volume":"215","author":[{"given":"Laura","family":"Loges","sequence":"first","affiliation":[{"name":"Department of Medicine 1, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gabel","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annkathrin","family":"Knauss","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-8433","authenticated-orcid":false,"given":"Raja","family":"Atreya","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Gessner","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU) , Erlangen,","place":["Germany"]},{"name":"METAB (Metabolomics Core Unit), FAU , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Bartels","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU) , Erlangen,","place":["Germany"]},{"name":"METAB (Metabolomics Core Unit), FAU , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F","family":"Neurath","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]},{"name":"Deutsches Zentrum Immuntherapie, Universit\u00e4tsklinikum Erlangen , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-0844","authenticated-orcid":false,"given":"Benno","family":"Weigmann","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg , Erlangen,","place":["Germany"]},{"name":"FAU Profile Center Immunomedicine, FAU , Erlangen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"2026090710431073200_vkag175-B1","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"2026090710431073200_vkag175-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J Immunol Res"},{"key":"2026090710431073200_vkag175-B3","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/ijms24032696","article-title":"CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease","volume":"24","author":"Gomez-Bris","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026090710431073200_vkag175-B4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.0019-2805.2004.01832.x","article-title":"Positive and negative adaptors in T-cell signalling","volume":"111","author":"Wilkinson","year":"2004","journal-title":"Immunology"},{"key":"2026090710431073200_vkag175-B5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ni0203-110","article-title":"Adaptors as central mediators of signal transduction in immune cells","volume":"4","author":"Jordan","year":"2003","journal-title":"Nat Immunol"},{"key":"2026090710431073200_vkag175-B6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nri1750","article-title":"SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond","volume":"6","author":"Koretzky","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2026090710431073200_vkag175-B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81422-1","article-title":"Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76","volume":"94","author":"Pivniouk","year":"1998","journal-title":"Cell"},{"key":"2026090710431073200_vkag175-B8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.183.4.1937","article-title":"Implication of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin 2 production","volume":"183","author":"Motto","year":"1996","journal-title":"J Exp Med"},{"key":"2026090710431073200_vkag175-B9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.281.5375.413","article-title":"Uncoupling of nonreceptor tyrosine kinases from PLC-\u03b31 in an SLP-76-deficient T cell","volume":"281","author":"Yablonski","year":"1998","journal-title":"Science"},{"key":"2026090710431073200_vkag175-B10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41467-020-20577-3","article-title":"Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis","volume":"12","author":"Yan","year":"2021","journal-title":"Nat Commun"},{"key":"2026090710431073200_vkag175-B11","doi-asserted-by":"crossref","first-page":"e20201062","DOI":"10.1084\/jem.20201062","article-title":"Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects","volume":"218","author":"Lev","year":"2020","journal-title":"J Exp Med"},{"key":"2026090710431073200_vkag175-B12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10875-022-01412-4","article-title":"SLP76 mutation associated with combined immunodeficiency and EBV-related lymphoma","volume":"43","author":"Lev","year":"2023","journal-title":"J Clin Immunol"},{"key":"2026090710431073200_vkag175-B13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaci.2023.04.020","article-title":"Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants","volume":"152","author":"Edwards","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2026090710431073200_vkag175-B14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2468-1253(24)00355-8","article-title":"Overcoming the challenges of overtreating and undertreating inflammatory bowel disease","volume":"10","author":"Temido","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026090710431073200_vkag175-B15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management","volume":"11","author":"Harbord","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2026090710431073200_vkag175-B16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","article-title":"Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab","volume":"67","author":"Laharie","year":"2018","journal-title":"Gut"},{"key":"2026090710431073200_vkag175-B17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026090710431073200_vkag175-B18","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"2026090710431073200_vkag175-B19","first-page":"83","article-title":"Pharmacokinetic disposition difference between cyclosporine and voclosporin drives their distinct efficacy and safety profiles in clinical studies","volume":"12","author":"Li","year":"2020","journal-title":"Clin Pharmacol"},{"key":"2026090710431073200_vkag175-B20","doi-asserted-by":"crossref","first-page":"1177450","DOI":"10.3389\/fmed.2023.1177450","article-title":"Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis","volume":"10","author":"Lindemann","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026090710431073200_vkag175-B21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1053\/j.gastro.2021.06.072","article-title":"Targeting of the Tec kinase ITK drives resolution of T cell\u2013mediated colitis and emerges as potential therapeutic option in ulcerative colitis","volume":"161","author":"Lechner","year":"2021","journal-title":"Gastroenterology"},{"key":"2026090710431073200_vkag175-B22","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1073\/pnas.0609771104","article-title":"SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK","volume":"104","author":"Bogin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090710431073200_vkag175-B23","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/ecco-jcc\/jjac097","article-title":"PU.1-driven Th9 cells promote colorectal cancer in experimental colitis models through Il-6 effects in intestinal epithelial cells","volume":"16","author":"Gerlach","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026090710431073200_vkag175-B24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/cpt.3017","article-title":"A metabolomic analysis of sensitivity and specificity of 23 previously proposed biomarkers for renal transporter-mediated drug-drug interactions","volume":"114","author":"Gessner","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"2026090710431073200_vkag175-B25","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"2026090710431073200_vkag175-B26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","article-title":"Amino assets: how amino acids support immunity","volume":"32","author":"Kelly","year":"2020","journal-title":"Cell Metab"},{"key":"2026090710431073200_vkag175-B27","doi-asserted-by":"crossref","first-page":"9328344","DOI":"10.1155\/2023\/9328344","article-title":"Clinical significance of carnitine in the treatment of cancer: from traffic to the regulation","volume":"2023","author":"Farahzadi","year":"2023","journal-title":"Oxid Med Cell Longev"},{"key":"2026090710431073200_vkag175-B28","doi-asserted-by":"crossref","first-page":"3150145","DOI":"10.1155\/2019\/3150145","article-title":"Unraveling the potential role of glutathione in multiple forms of cell death in cancer therapy","volume":"2019","author":"Lv","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"2026090710431073200_vkag175-B29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat Commun"},{"key":"2026090710431073200_vkag175-B30","doi-asserted-by":"crossref","first-page":"115804","DOI":"10.1016\/j.celrep.2025.115804","article-title":"Cell death and cancer: metabolic interconnections","volume":"44","author":"Dalseno","year":"2025","journal-title":"Cell Rep"},{"key":"2026090710431073200_vkag175-B31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"key":"2026090710431073200_vkag175-B32","doi-asserted-by":"crossref","first-page":"1750826","DOI":"10.3389\/fmed.2026.1750826","article-title":"Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis","volume":"13","author":"Gabel","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"2026090710431073200_vkag175-B33","doi-asserted-by":"crossref","first-page":"3000605211059681","DOI":"10.1177\/03000605211059681","article-title":"Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma","volume":"49","author":"Huo","year":"2021","journal-title":"J Int Med Res"},{"key":"2026090710431073200_vkag175-B34","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3324\/haematol.2015.139154","article-title":"SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course","volume":"101","author":"Dezorella","year":"2016","journal-title":"Haematologica"},{"key":"2026090710431073200_vkag175-B35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12957-017-1181-9","article-title":"A putative molecular network associated with colon cancer metastasis constructed from microarray data","volume":"15","author":"Chu","year":"2017","journal-title":"World J Surg Oncol"},{"key":"2026090710431073200_vkag175-B36","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2009-08-237438","article-title":"Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production","volume":"115","author":"Sonnenberg","year":"2010","journal-title":"Blood"},{"key":"2026090710431073200_vkag175-B37","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat Immunol"},{"key":"2026090710431073200_vkag175-B38","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/cells12202440","article-title":"Voclosporin: unique chemistry, pharmacology and toxicity profile, and possible options for implementation into the management of lupus nephritis","volume":"12","author":"Kale","year":"2023","journal-title":"Cells"},{"key":"2026090710431073200_vkag175-B39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"2026090710431073200_vkag175-B40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/FPC.0b013e328364db84","article-title":"PharmGKB summary: cyclosporine and tacrolimus pathways","volume":"23","author":"Barbarino","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"2026090710431073200_vkag175-B41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","article-title":"Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development","volume":"52","author":"Hwang","year":"2020","journal-title":"Exp Mol Med"},{"key":"2026090710431073200_vkag175-B42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jlb.63.2.139","article-title":"Transcriptional regulation in the immune system: all roads lead to AP-1","volume":"63","author":"Foletta","year":"1998","journal-title":"J Leukoc Biol"},{"key":"2026090710431073200_vkag175-B43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur J Immunol"},{"key":"2026090710431073200_vkag175-B44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BCJ20200661","article-title":"Extracellular signal-regulated kinase (ERK) pathway control of CD8+ T cell differentiation","volume":"478","author":"Damasio","year":"2021","journal-title":"Biochem J"},{"key":"2026090710431073200_vkag175-B45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4+ T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"2026090710431073200_vkag175-B46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cca.2010.12.020","article-title":"MAP kinases in inflammatory bowel disease","volume":"412","author":"Coskun","year":"2011","journal-title":"Clin Chim Acta"},{"key":"2026090710431073200_vkag175-B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)13074-3","article-title":"Activation and deactivation of gene expression by Ca2+\/calcineurin-NFAT-mediated signaling","volume":"18","author":"Im","year":"2004","journal-title":"Mol Cells"},{"key":"2026090710431073200_vkag175-B48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fimmu.2017.00153","article-title":"Targeting the monocyte-macrophage lineage in solid organ transplantation","volume":"8","author":"van den Bosch","year":"2017","journal-title":"Front Immunol"},{"key":"2026090710431073200_vkag175-B49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"2026090710431073200_vkag175-B50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ibd\/izab277","article-title":"Excessive apoptosis in ulcerative colitis: crosstalk between apoptosis, ROS, ER stress, and intestinal homeostasis","volume":"28","author":"Wan","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2026090710431073200_vkag175-B51","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.3390\/ijms22147426","article-title":"Programmed cell death in the small intestine: implications for the pathogenesis of celiac disease","volume":"22","author":"Perez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026090710431073200_vkag175-B52","doi-asserted-by":"crossref","first-page":"1127618","DOI":"10.3389\/fcell.2023.1127618","article-title":"Role of amino acid metabolism in mitochondrial homeostasis","volume":"11","author":"Li","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"2026090710431073200_vkag175-B53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s44324-025-00067-0","article-title":"The role of NAD+ metabolism and its modulation of mitochondria in aging and disease","volume":"3","author":"Yusri","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"2026090710431073200_vkag175-B54","first-page":"66","article-title":"Antioxidant action of carnitine: molecular mechanisms and practical applications","author":"Surai","year":"2015","journal-title":"EC Vet Sci."},{"key":"2026090710431073200_vkag175-B55","first-page":"109","article-title":"Malate-aspartate shuttle mediates the intracellular ATP levels, antioxidation capacity and survival of differentiated PC12 cells","volume":"6","author":"Wang","year":"2014","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"2026090710431073200_vkag175-B56","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/iub.2367","article-title":"The malate\u2013aspartate shuttle (Borst cycle): how it started and developed into a major metabolic pathway","volume":"72","author":"Borst","year":"2020","journal-title":"IUBMB Life"},{"key":"2026090710431073200_vkag175-B57","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.cmet.2024.05.014","article-title":"Electron transport chain inhibition increases cellular dependence on purine transport and salvage","volume":"36","author":"Wu","year":"2024","journal-title":"Cell Metab"},{"key":"2026090710431073200_vkag175-B58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41419-022-04527-z","article-title":"Adenine overload induces ferroptosis in human primary proximal tubular epithelial cells","volume":"13","author":"Khan","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026090710431073200_vkag175-B59","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1432-2277.2004.tb00509.x","article-title":"The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro","volume":"17","author":"B\u00eersan","year":"2004","journal-title":"Transplant Int"},{"key":"2026090710431073200_vkag175-B60","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat Rev Immunol"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/7\/vkag175\/70043620\/vkag175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/7\/vkag175\/70043620\/vkag175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:43:24Z","timestamp":1788792204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/doi\/10.1093\/jimmun\/vkag175\/8741916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkag175","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"vkag175"}}